A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GMTs / geometric mean antibody titers

[Related PubMed/MEDLINE]
Total Number of Papers: 23
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GMTs  (>> Co-occurring Abbreviation)
Long Form:   geometric mean antibody titers
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis. IPV, OPV, PROSPERO
2018 Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico. ATP, DENV, DPIV
2014 Comparison of the immunogenicity of Cervarix and Gardasil human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults. HIV, HPV, PBNA
2014 Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials. HPV, VLP
2014 Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda. HPV
2014 Prevalence and titre of antibodies against Hepatitis A virus in HIV-infected men having sex with men in Greece. anti-HAV, MSM
2013 Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults. AEs, HAI, QIV, SAEs, TIVs
2012 Immune response to hepatitis A vaccination in HIV-infected men in Greece. HAV
2012 Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. HAB, HPV
10  2012 The investigational meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate vaccine (ACWY-TT) and the seasonal influenza virus vaccine are immunogenic and well-tolerated when co-administered in adults. ACWY-TT, CHMP, HI, MenPS
11  2011 Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. ELISA, GMR, GSK, HPV, PBNA
12  2011 Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years. ELISA
13  2003 Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine. ---
14  2002 Lactogenic antibody responses in cows vaccinated with recombinant bovine rotavirus-like particles (VLPs) of two serotypes or inactivated bovine rotavirus vaccines. BRV, PPD, VLPs, VLPs
15  1999 Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population. HI
16  1998 Concomitant vaccination against hepatitis A and typhoid fever. ---
17  1998 Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules. Multicenter Working Group. DTPa-HB, FHA, HB, PRN
18  1996 Epstein-Barr virus and familial Hodgkin's disease. EA-D, EBV, FHD, HD, UFM, VCA
19  1996 Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine. Hib, HIV, Pa
20  1995 Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans. AST, HAV
21  1995 Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. ---
22  1994 Four-year follow-up of the immune status of young adults given a single booster dose of trivalent oral poliovaccine. ---
23  1993 Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children. FHA, PT